Identification of genes selectively regulated by IFNs in endothelial cells

Journal of Immunology

Volumn 178, Issue 2, 2007, Pages 1122-1135

  Indraccolo, Stefano ^a   Pfeffer, Ulrich ^b   Minuzzo, Sonia ^c   Esposito, Giovanni ^a   Roni, Valeria ^d   Mandruzzato, Susanna ^c   Ferrari, Nicoletta ^b   Anfosso, Luca ^b,e   Dell'Eva, Raffaella ^b   Noonan, Douglas M ^e   Chieco Bianchi, Luigi ^c   Albini, Adriana ^f   Amadori, Alberto ^a,c  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CXCL11 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERFERON; MESSENGER RNA; TRANSCRIPTOME; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADOLESCENT; ANGIOGENESIS; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GENE; GENE ACTIVATION; GENE CONTROL; GENE IDENTIFICATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; INTERFERON RESPONSIVE GENE; MALE; MOUSE; NONHUMAN; PLEIOTROPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA VIRUS;

EID: 33846255059     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.2.1122     Document Type: Article

References (48)

1. Sidky, Y. A., and E. C. Borden. 1987. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res. 47: 5155-5161.
2. Rozera, C., D. Carlei, P. L. Lollini, C. De Giovanni, P. Musiani, E. Di Carlo, F. Belardelli, and M. Ferrantini. 1999. Interferon (IFN)-β gene transfer into TS/A adenocarcinoma cells and comparison with IFN-α: differential effects on tumorigenicity and host response. Am. J. Pathol. 154: 1211-1222.
3. Albini, A., C. Marchisone, F. Del Grosso, R. Benelli, L. Masiello, C. Tacchetti, M. Bono, M. Ferrantini, C. Rozera, M. Truini, et al. 2000. Inhibition of angiogenesis and vascular tumor growth by interferon- producing cells: a gene therapy approach. Am. J. Pathol. 156: 1381-1393.
4. Indraccolo, S., E. Gola, A. Rosato, S. Minuzzo, W. Habeler, V. Tisato, V. Roni, G. Esposito, M. Morini, A. Albini, et al. 2002. Differential effects of angiostatin, endostatin and interferon-α(1) gene transfer on in vivo growth of human breast cancer cells. Gene Ther. 9: 867-878.
5. Singh, R. K., M. Gutman, C. D. Bucana, R. Sanchez, N. Llansa, and I. J. Fidler. 1995. Interferons α and β down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Natl. Acad. Sci. USA 92: 4562-4566.
6. Oliveira, I. C., N. Mukaida, K. Matsushima, and J. Vilcek. 1994. Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-κB site. Mol. Cell. Biol. 14: 5300-5308.
7. von Marschall, Z., A. Scholz, T. Cramer, G. Schafer, M. Schirner, K. Oberg, B. Wiedenmann, M. Hocker, and S. Rosewicz. 2003. Effects of interferon α on vascular endothelial growth factor gene transcription and tumor angiogenesis. J. Natl. Cancer Inst. 95: 437-448.
8. De Bouard, S., J. S. Guillamo, C. Christov, N. Lefevre, P. Brugieres, E. Gola, P. Devanz, S. Indraccolo, and M. Peschanski. 2003. Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-α, angiostatin, or endostatin. Hum. Gene Ther. 14: 883-895.
9. Friesel, R., A. Komoriya, and T. Maciag. 1987. Inhibition of endothelial cell proliferation by γ-interferon. J. Cell Biol. 104: 689-696.
10. Angiolillo, A. L., C. Sgadari, D. D. Taub, F. Liao, J. M. Farber, S. Maheshwari, H. K. Kleinman, G. H. Reaman, and G. Tosato. 1995. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182: 155-162.
11. Sgadari, C., A. L. Angiolillo, B. W. Cherney, S. E. Pike, J. M. Farber, L. G. Koniaris, P. Vanguri, P. R. Burd, N. Sheikh, G. Gupta, et al. 1996. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc. Natl. Acad. Sci. USA 93: 13791-13796.
12. Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95: 15623-15628.
13. Krepler, C., U. Certa, V. Wacheck, B. Jansen, K. Wolff, and H. Pehamberger. 2004. Pegylated and conventional interferon-α induce comparable transcriptional responses and inhibition of tumor growth in a human melanoma SCID mouse xenotransplantation model. J. Invest. Dermatol. 123: 664-669.
14. Tracey, L., I. Spiteri, P. Ortiz, M. Lawler, M. A. Piris, and R. Villuendas. 2004. Transcriptional response of T cells to IFN-α: changes induced in IFN-α-sensitive and resistant cutaneous T cell lymphoma. J. Interferon Cytokine Res. 24: 185-195.
15. Ji, X., R. Cheung, S. Cooper, Q. Li, H. B. Greenberg, and X. S. He. 2003. Interferon α regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology 37: 610-621.
16. Taylor, M. W., W. M. Grosse, J. E. Schaley, C. Sanda, X. Wu, S. C. Chien, F. Smith, T. G. Wu, M. Stephens, M. W. Ferris, et al. 2004. Global effect of PEG-IFN-α and ribavirin on gene expression in PBMC in vitro. J. Interferon Cytokine Res. 24: 107-118.
17. Schlaak, J. F., C. M. Hilkens, A. P. Costa-Pereira, B. Strobl, F. Aberger, A. M. Frischauf, and I. M. Kerr. 2002. Cell-type and donor-specific transcriptional responses to interferon-α. Use of customized gene arrays. J. Biol. Chem. 277: 49428-49437.
18. de Veer, M. J., M. Holko, M. Frevel, E. Walker, S. Der, J. M. Paranjape, R. H. Silverman, and B. R. Williams. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukocyte Biol. 69: 912-920.
19. Roni, V., W. Habeler, A. Parenti, S. Indraccolo, E. Gola, V. Tosello, R. Cortivo, G. Abatangelo, L. Chieco-Bianchi, and A. Amadori. 2003. Recruitment of human umbilical vein endothelial cells and human primary fibroblasts into experimental tumors growing in SCID mice. Exp. Cell Res. 287: 28-38.
20. Irizarry, R. A., B. M. Bolstad, F. Collin, L. M. Cope, B. Hobbs, and T. P. Speed. 2003. Summaries of Affymetrix gene chip probe level data. Nucleic Acids Res. 31: e15.
21. Zhang, J., V. Carey, and R. Gentleman. 2003. An extensible application for assembling annotation for genomic data. Bioinformatics 19: 155-156.
22. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98: 5116-5121.
23. Dennis, G., Jr., B. T. Sherman, D. A. Hosack, J. Yang, W. Gao, H. C. Lane, and R. A. Lempicki. 2003. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 4: P3.
24. Rosen, S. and H. J. Skaletsky. 2000. Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology. S. Misener and S. A. Krawetz, eds. Humana Press, Totewa, NJ, p. 365-386.
25. Muller, P. Y., H. Janovjak, A. R. Miserez, and Z. Dobbie. 2002. Processing of gene expression data generated by quantitative real-time RT-PCR. BioTechniques 32: 1372-1379.
26. Albini, A., G. Fontanini, L. Masiello, C. Tacchetti, D. Bigini, P. Luzzi, D. M. Noonan, and W. G. Stetler-Stevenson. 1994. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS 8: 1237-1244.
27. Chin, K. C., and P. Cresswell. 2001. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc. Natl. Acad. Sci. USA 98: 15125-15130.
28. Bluyssen, H. A., R. J. Vlietstra, P. W. Faber, E. M. Smit, A. Hagemeijer, and J. Trapman. 1994. Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family. Genomics 24: 137-148.
29. Strieter, R. M., J. A. Belperio, R. J. Phillips, and M. P. Keane. 2004. CXC chemokines in angiogenesis of cancer. Semin. Cancer Biol. 14: 195-200.
30. Cassatella, M. A., V. Huber, F. Calzetti, D. Margotto, N. Tamassia, G. Peri, A. Mantovani, L. Rivoltini, and C. Tecchio. 2005. Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators. J. Leukocyte Biol. 79: 123-132.
31. Sana, T. R., M. J. Janatpour, M. Sathe, L. M. McEvoy, and T. K. McClanahan. 2005. Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 29: 256-269.
32. Kerbel, R., and J. Folkman. 2002. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2: 727-739.
33. Marler, J. J., J. B. Rubin, N. S. Trede, S. Connors, H. Grier, J. Upton, J. B. Mulliken, and J. Folkman. 2002, Successful antiangiogenic therapy of giant cell angioblastoma with interferon α 2b: report of 2 cases. Pediatrics 109: E37.
34. Chang, E., A. Boyd, C. C. Nelson, D. Crowley, T. Law, K. M. Keough, J. Folkman, R. A. Ezekowitz, and V. P. Castle. 1997. Successful treatment of infantile hemangiomas with interferon-α-2b. J. Pediatr. Hematol. Oncol. 19: 237-244.
35. da Silva, A. J., M. Brickelmaier, G. R. Majeau, A. V. Lukashin, J. Peyman, A. Whitty, and P. S. Hochman. 2002. Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-α 2b vs. IFN-β 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J. Interferon Cytokine Res. 22: 173-188.
36. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264.
37. Romagnani, P., L. Lasagni, F. Annunziato, M. Serio, and S. Romagnani. 2004. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol. 25: 201-209.
38. Romagnani, P., F. Annunziato, L. Lasagni, E. Lazzeri, C. Beltrame, M. Francalanci, M. Uguccioni, G. Galli, L. Cosmi, L. Maurenzig, et al. 2001. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107: 53-63.
39. Lasagni, L., M. Francalanci, F. Annunziato, E. Lazzeri, S. Giannini, L. Cosmi, C. Sagrinati, B. Mazzinghi, C. Orlando, E. Maggi, et al. 2003. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197: 1537-1549.
40. Alladina, S. J., J. H. Song, S. T. Davidge, C. Hao, and A. S. Easton. 2005. TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase/Akt through the short form of cellular FLIP and Bcl-2. J. Vasc. Res. 42: 337-347.
41. Secchiero, P., A. Gonelli, E. Carnevale, D. Milani, A. Pandolfi, D. Zella, and G. Zauli. 2003. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 107: 2250-2256.
42. Cheng, Y. S., R. J. Colonno, and F. H. Yin. 1983. Interferon induction of fibroblast proteins with guanylate binding activity. J. Biol. Chem. 258: 7746-7750.
43. Anderson, S. L., J. M. Carton, J. Lou, L. Xing, and B. Y. Rubin. 1999. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256: 8-14.
44. Naschberger, E., T. Werner, A. B. Vicente, E. Guenzi, K. Topolt, R. Leubert, C. Lubeseder-Martellato, P. J. Nelson, and M. Sturzl. 2004. Nuclear factor-κB motif and interferon-α-stimulated response element cooperate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. Biochem. J. 379: 409-420.
45. Guenzi, E., K. Topolt, E. Cornali, C. Lubeseder-Martellato, A. Jorg, K. Matzen, C. Zietz, E. Kremmer, F. Nappi, M. Schwemmle, C. Hohenadl, et al. 2001. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J. 20: 5568-5577.
46. Guenzi, E., K. Topolt, C. Lubeseder-Martellato, A. Jorg, E. Naschberger, R. Benelli, A. Albini, and M. Sturzl. 2003. The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J. 22: 3772-3782.
47. Lubeseder-Martellato, C., E. Guenzi, A. Jorg, K. Topolt, E. Naschberger, E. Kremmer, C. Zietz, E. Tschachler, P. Hutzler, M. Schwemmle, et al. 2002. Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am. J. Pathol. 161: 1749-1759.
48. Burdick, M. D., L. A. Murray, M. P. Keane, Y. Y. Xue, D. A. Zisman, J. A. Belperio, and R. M. Strieter. 2005. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. Am. J. Respir. Crit. Care Med. 171: 261-268.